The site selection process is complicated by outdated data, limited operational insight, and overreliance on reputation. Discover some practical ways to evaluate site feasibility for your next trial.
- Heading For An M&A? Understand The Risks And Mitigation Strategies For Clinical Trial Agreements
- Sites Are 3X Likely To Die In The First Year Than New Businesses
- Sponsors Collect Too Much "Non-Essential" Data, Say Tufts And TransCelerate
- Two Former FDA Chiefs, Two Very Different Warnings
- Global Implications Of Zero Tariffs On Indian Pharma Exports To China
- Participant Recruitment In LMIC Clinical Trials
- Behavior Modeling Can Help Sponsors Better Understand Sites And Patients
GUEST COLUMNISTS
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Behavior Modeling Can Help Sponsors Better Understand Sites And PatientsLearn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
-
![China and united states flag-GettyImages-1089423344]( "How The U.S. Can Beat China In Biotech")
How The U.S. Can Beat China In BiotechLumen Bioscience's Brian Finrow breaks down China's biotech playbook and explores ways the U.S. can adapt it for its own continued success.
-
![Businesswoman walking in crowd-GettyImages-2208884463]( "How AI Is Transforming Patient Stratification")
How AI Is Transforming Patient StratificationDiscover how AI tools can help stratify or group patients into subtypes that respond differently to treatment.
-
![colorful arrows pointing up-GettyImages-2152056193]( "The Rise Of Specialist CROs In Clinical Outsourcing")
The Rise Of Specialist CROs In Clinical OutsourcingUnderstand the trends behind the growing specialist CRO sector.
-
![Online documentation database, AI, artificial intelligence, dms, GettyImages-2078225287]( "How AI Is Rewriting The Future Of TMF And Clinical Quality")
How AI Is Rewriting The Future Of TMF And Clinical QualityDiscover how AI is transforming the TMF from a reactive repository into a proactive, intelligent co-pilot for clinical trials.
-
![beroe_raredisease3-gettyimages-1629549075]( "Trends In Rare Disease Trials: Recommendations")
Trends In Rare Disease Trials: RecommendationsIn the third article of this series, analyst reveal their top 6 recommendations for designing selection criteria and selecting solution options to optimize rare disease research outcomes.
-
![Senior man at clinic reception desk-GettyImages-2174582061]( "The Hidden Power Of Specialized Community Research Sites In Accelerating Clinical Trials")
The Hidden Power Of Specialized Community Research Sites In Accelerating Clinical TrialsTyler Research Institute founder G. Aaron DuVall explores how community sites can offer access to diverse patient populations and build processes tailored for chronic disease care to accelerate timelines and improve outcomes.
-
![Career Path-GettyImages-2239749438]( "Regulatory Pathways — With Real-Life Examples — For Successful CGT Clinical Trials")
Regulatory Pathways — With Real-Life Examples — For Successful CGT Clinical TrialsDiscover the most effective regulatory pathways used to support CGT development, including two real-life examples.
CLINICAL TRIAL WHITE PAPERS
-
![GettyImages-1445871463 supply chain]( "Navigating The FDA's Drug Supply Chain Security Act")
Navigating The FDA's Drug Supply Chain Security ActExplore the transformative impact of the DSCSA on the pharmaceutical industry, which ensures stringent standards, prevents counterfeit drugs, and enhances traceability for both large corporations and small manufacturers.
-
Consider India For Your Next HCC International Trial11/16/2023
Assess the feasibility of India as a potential venue for HCC trials as well as its epidemiology, historical perceptions, and untapped potential for international clinical research opportunities.
-
Enhancing Clinical Trial Flexibility9/1/2025
Once seen primarily as staffing extensions, FSPs have evolved into strategic partners that deliver flexibility, scalability, and tailored expertise.
-
Outlook Good For 7 Drugs Up For Q3 Review8/15/2024
A total of 24 drugs, devices, diagnostics, and deals are expected to progress in the third quarter of 2024, including approval applications for 17 drugs. The estimated overall likelihood of approval is 90% or higher for seven of those drugs, including revumenib for acute myelogenous leukemia and KarXT for schizophrenia.
-
The Hidden Problem In Early Phase Oncology Trials9/23/2025
Integrating patient-reported outcome measures (PROMs) can enable improved capture tolerability and optimize dosing decisions.
-
Patient-Reported Outcome In Oncology Clinical Trials4/17/2025
As cancer therapies grow more complex and personalized, patient-reported outcomes (PROs) have emerged as a vital component of oncology research and care.
CLINICAL TRIAL APP NOTES & CASE STUDIES
-
Data-Driven Physician Engagement For Ultra-Rare Diseases2/3/2025
How can an effective partnership help you to utilize advanced data analytics to address the significant challenges of clinical trials centered around ultra-rare diseases?
-
Educating Globally Diverse Populations Through Branding & Visuals10/31/2024
See how this customized educational approach significantly enhanced recruitment and retention efforts, helping to ensure a more inclusive trial for Nonobstructive Hypertrophic Cardiomyopathy (nHCM).
-
Setting A New Client Standard In Study Closeout Timelines4/4/2025
Learn how a top-10 global pharmaceutical company achieved a significantly faster time to market for a high-profile therapy.
-
Medable Platform Delivers >90% eCOA Adherence And Scalability7/8/2024
Discover how eCOA use drove >90% adherence across an extensive weight management master protocol clinical trial with multiple sub-studies across 70+ research sites.
-
Duchenne Muscular Dystrophy Trial In China9/17/2025
A global sponsor conducting a Duchenne Muscular Dystrophy trial in China required reliable patient travel solutions to support children and families.
-
How We Used Intelligent Automation to Transform Vendor Selection7/2/2025
Discover how your small biotech can achieve faster timelines, improved cost control, and more strategic, transparent choices with a platform leveraging intelligent automation.
NEWSLETTER ARCHIVE
- 11.14.25 -- Why CRA Proficiency Needs A Boost From Better Assessment And Training
- 11.14.25 -- Less Workload, More Patient Time: Elevating The Site Voice
- 11.13.25 -- The Rise Of Specialist CROs In Clinical Outsourcing
- 11.13.25 -- From Chaos To Control: Modernizing Data And Mastering Clinical Trials
- 11.12.25 -- Ask An Expert Before Shredding Your Mobile Device CAPEX
RECRUITMENT AND DIVERSITY
This section includes some helpful resources regarding patient recruitment and diversity in clinical trials, including this link to the FDA's guidance on diversity action plans.
-
![metaverse technology-GettyImages-1372364665]( "Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs")
Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.
-
![community nurse with three teens-GettyImages-1442937688]( "Participant Recruitment In LMIC Clinical Trials")
Due to the high burden of infectious diseases in low- and middle-income countries (LMICs), there is greater urgency for vaccine trials. Participant recruitment entails significant work with communities.
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
FOCUS ON PATIENTS
-
![metaverse technology-GettyImages-1372364665]( "Non-Invasive Brain-Computer Interface Trial Balances Regulatory Requirements With Patient Needs")
Cognixion CTO Chris Ullrich introduces the Axon-R Nucleus bio-sensing hub and discusses its feasibility trial, highlighting the importance of patient input, caregiver quality of life, and regulatory support.
-
![Human mind, experience diversity, personality characteristics-GettyImages-2203518410]( "Behavior Modeling Can Help Sponsors Better Understand Sites And Patients")
Learn how behavioral modeling can identify patients at risk of dropout and sites that may need additional support, so you can build a more resilient research network.
-
![sunlit brain puzzle-GettyImages-2187021354]( "How Redefining The Diagnostic Odyssey Can Lead To Better Patient Outcomes")
Patient advocate Wendy Cogan calls for improved diagnostic pathways as a means to better clinical trial recruitment and design while telling the journey of her late husband's journey to a corticobasal degeneration(CBD)-frontal behavioral-spatial syndrome (FBS) diagnosis.
